- Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: NVA237 50 µg and indacaterol 150 µg; Drug: Placebo to NVA237 and indacaterol 150 µg
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: COPD
Interventions: Device: Omnilab - AVAPS AE algorithm; Device: Usual care
Sponsors: Guy's and St Thomas' NHS Foundation Trust; Patrick Murphy; Philips Respironics
Recruiting - verified May 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Chronic Bronchitis
Interventions: Drug: N-acetylcysteine; Drug: Oral acetylcysteine
Sponsors: Minnesota Veterans Research Institute; Minnesota Veterans Research Institute
Not yet recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: theophylline; Other: placebo
Sponsors: Hospital Son Espases; Hospital Son Espases; Spanish Research Center for Respiratory Diseases; Fundación Mutua Madrileña
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Roflumilast 500; Drug: Placebo
Sponsors: Spanish Research Center for Respiratory Diseases; Spanish Research Center for Respiratory Diseases
Not yet recruiting - verified May 2012 - Condition: Chronic Obstructive Lung Disease
Intervention: Device: Breathe NIOV Ventilator
Sponsors: Breathe Technologies, Inc.; Breathe Technologies, Inc.; Tufts Medical Center
Not yet recruiting - verified May 2012 - Conditions: Multiple Conditions; Coronary Heart Disease; Diabetes; Hypertension; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: University of Southampton; University of Southampton
Not yet recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Radiation: Functional Imaging; Other: Lung compliance measurement; Device: Non-invasive ventilation (Respironics, Air Liquide)
Sponsors: FluidDA nv; FluidDA nv
Recruiting - verified May 2012 - Conditions: Smoking; Drinking
Intervention: Behavioral: Combined BNI
Sponsors: Yale University; Yale University
Not yet recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: PT003; Drug: PT001; Drug: PT005; Drug: Tiotropium inhalation powder
Sponsors: Pearl Therapeutics, Inc.; Pearl Therapeutics, Inc.
Recruiting - verified April 2012 - Condition: Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: CHF1535 + CHF5992 dose 1 BID; Drug: CHF1535 + CHF5992 dose2 BID; Drug: CHF1535 daily dose
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Not yet recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive (COPD)
Interventions: Other: Usual care; Other: self-monitoring for patients with severe COPD; Other: nurse-monitoring for patients with severe COPD
Sponsors: Landeskrankenanstalten-Betriebsgesellschaft; Landeskrankenanstalten-Betriebsgesellschaft; European Commission
Recruiting - verified April 2012 - Conditions: Emphysema; Poor Sleep Quality
Interventions: Drug: Budesonide/formoterol 160/4.5 mcg; Drug: Placebo
Sponsors: Temple University; Temple University
Recruiting - verified May 2012 - Condition: Pulmonary Artery Hypertension
Intervention:
Sponsors: University of Pittsburgh; University of Pittsburgh
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: aprepitant; Drug: placebo
Sponsors: Dartmouth-Hitchcock Medical Center; Dartmouth-Hitchcock Medical Center
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Procedure: Osteopathic Manipulative Treatment (OMT); Other: sham omt
Sponsors: Michigan State University; Michigan State University
Not yet recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: Mindfulness meditation
Sponsors: University of Michigan; University of Michigan
Recruiting - verified April 2012 - Condition: Pulmonary Emphysema
Intervention: Device: EBV
Sponsors: Pulmonx, Inc.; Pulmonx International Sàrl
Not yet recruiting - verified April 2012 - Condition: Symptomatic Bronchiectasis
Intervention: Drug: Roflumilast
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Not yet recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: QVA149; Drug: Placebo to tiotropium; Drug: Placebo to formoterol; Drug: Tiotropium; Drug: Formoterol; Drug: Placebo to QVA149
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Condition: COPD
Interventions: Drug: roflumilast; Drug: placebo
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Not yet recruiting - verified April 2012 - Condition: COPD
Interventions: Drug: AZD8683; Drug: Placebo
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified April 2012 - Conditions: Respiratory Failure; Self Efficacy
Intervention: Device: Intellivent; automatic mode implemented on a S1 ventilator
Sponsors: Hamilton Medical AG; Hamilton Medical AG
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Inhaled GSK573719; Drug: Inhaled GSK573719/vilanterol
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: NVA237; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention:
Sponsors: University of Aarhus; University of Aarhus; Aarhus University Hospital
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: exercise
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Procedure: Adipose-Derived Stem Cell (ADSC) Therapy
Sponsors: Ageless Regenerative Institute; Ageless Regenerative Institute; Instituto de Medicina Regenerativa, S.A. de C.V.
Recruiting - verified March 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: tiotropium; Drug: olodaterol; Drug: olodaterol; Drug: olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol; Drug: tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Neuromuscular Disease; Chest Wall Disorders; Obesity Hypoventilation Syndrome
Interventions: Device: Telemonitoring tools; Device: Usual Care
Sponsors: Hospital Sao Joao; Hospital Sao Joao
Not yet recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: AZD5423; Drug: Budesonide; Drug: Placebo
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol; Drug: Salmeterol/fluticasone
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Congestive Heart Failure
Interventions: Device: Spirotiger; Other: Control group
Sponsors: Fondazione Salvatore Maugeri; Fondazione Salvatore Maugeri
Recruiting - verified March 2012 - Condition: COPD
Intervention:
Sponsors: Politecnico di Milano; Raffaele Dellaca; Restech srl - spinoff del Politecnico di Milano; Politecnico di Milano; Fondazione Salvatore Maugeri; Azienda Ospedaliera S. Luigi, Orbassano (TO); Baylor College of Medicine
Recruiting - verified March 2012 - Conditions: COPD,; Osteoporosis
Intervention: Behavioral: mobile-based PR program.
Sponsors: Chang Gung Memorial Hospital; Chang Gung Memorial Hospital
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Behavioral: Tai chi; Behavioral: Mind-body breathing; Behavioral: Education
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified March 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/VI; Other: Existing Maintenance Therapy
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: Inspiratory muscle training
Sponsors: University Hospital, Brest; University Hospital, Brest; Ministry of Health, France
Recruiting - verified March 2012 - Conditions: Asthma; Chronic Obstructive Pulmonary Disease; Obstructive Sleep Apnea
Intervention: Drug: Inhaled Fluticasone Propionate
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Conditions: COPD; Smoking; Other Diagnoses, Comorbidities, and Complications
Intervention:
Sponsors: Children's Hospital Srebrnjak; Children's Hospital Srebrnjak; GlaxoSmithKline; University Hospital Rijeka; Clinical Hospital Center, Split; General Hospital Dubrovnik; Institute for Medical Research and Occupational Health, Zagreb
Recruiting - verified March 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: COPD
Interventions: Drug: indacaterol; Drug: placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified February 2012 - Conditions: Chronic Obstructive Lung Disease; Rhinitis
Intervention:
Sponsors: Haukeland University Hospital; Haukeland University Hospital
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: RT management; Other: Ususal care
Sponsors: Barnes-Jewish Hospital Foundation; Barnes-Jewish Hospital Foundation
Not yet recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Losmapimod; Drug: Placebo
Sponsors: Cambridge University Hospitals NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Technology Strategy Board; GlaxoSmithKline; Royal Brompton & Harefield NHS Foundation Trust; University of Cambridge
Not yet recruiting - verified February 2012 - Conditions: Weaning Failure; COPD Exacerbation
Interventions: Other: pressure support ventilation; Other: Pressure controlled ventilation
Sponsors: Centre Hospitalier Universitaire, Amiens; Centre Hospitalier Universitaire, Amiens
Recruiting - verified October 2011 - Conditions: Oxygen Dependent COPD; Advanced Malignancy
Interventions: Behavioral: Informed Assent; Behavioral: Informational Brochure
Sponsors: University of Vermont; University of Vermont
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: SERETIDE Rotacaps; Drug: SERETIDE Diskus
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Respiratory System
Interventions: Drug: Ciprofloxacin (Cipro Inhale, BAYQ3939); Drug: Ciprofloxacin (Cipro Inhale, BAYQ3939); Drug: Ciprofloxacin (Cipro Inhale, BAYQ3939); Drug: Ciprofloxacin (Cipro Inhale, BAYQ3939)
Sponsors: Bayer; Bayer
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium + Olodaterol; Drug: Olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Postoperative Pain.
Interventions: Drug: Subpleural pain catheter with infusion of 0.125% bupivacaine; Drug: Standard acute pain management
Sponsors: Inova Health Care Services; Inova Health Care Services
Not yet recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Physical training; Other: Physical training
Sponsors: Universidade Estadual de Londrina; Universidade Estadual de Londrina; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: olodaterol; Drug: olodaterol; Drug: Tiotropium; Drug: Tiotropium; Drug: Oldaterol; Drug: Tiotropium + olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium; Drug: Olodaterol; Drug: Tiotropium; Drug: tiotropium + olodaterol; Drug: Olodaterol; Drug: Olodaterol; Drug: tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Behavioral: Behavioural intervention; Behavioral: Usual care group
Sponsors: Uppsala University; Uppsala University; Umeå University
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: QVA149; Drug: NVA237; Drug: QAB149; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium+olodaterol; Drug: tiotropium + olodaterol (high dose); Drug: placebo to tiotropium+olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Salmeterol
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified April 2012 - Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung DiseaseConditions: Chronic Lung Disease; Self-efficacy
Intervention:
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified April 2012 - Conditions: Anxiety; COPD
Intervention: Drug: escitalopram
Sponsors: Hull and East Yorkshire Hospitals NHS Trust; Hull and East Yorkshire Hospitals NHS Trust
Not yet recruiting - verified January 2012 - Conditions: Smoking; Airway Obstruction
Intervention: Drug: Salbutamol sulphate
Sponsors: Rio de Janeiro State University; Rio de Janeiro State University; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Recruiting - verified January 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Anxiety; Depression
Intervention: Behavioral: Psychiatric Counselling
Sponsors: Fundacion Clinic per a la Recerca Biomédica; Nestor Soler Porcar
Recruiting - verified January 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Hypercapnic Respiratory Failure
Intervention: Device: Non Invasive Ventilation- Device is: VPAP ST (Resmed, Australia)
Sponsors: University Hospital, Rouen; University Hospital, Rouen
Recruiting - verified February 2012 - Condition: Lung Neoplasms
Intervention:
Sponsors: Sheba Medical Center; Sheba Medical Center
Not yet recruiting - verified February 2012 - Conditions: Chronic Obstructive Pulmonary Disease (COPD); Decompensated COPD With (Acute) Exacerbation
Interventions: Other: Spontaneous Breathing; Other: Non Invasive Mechanical Ventilation
Sponsors: University Hospital, Caen; University Hospital, Caen
Recruiting - verified January 2012 - Condition: Pulmonary Emphysema
Interventions: Device: Emphysematous Lung Sealant; Device: Emphysematous Lung Sealant
Sponsors: Aeris Therapeutics; Aeris Therapeutics
Not yet recruiting - verified January 2012 - Condition: Pulmonary Emphysema
Intervention:
Sponsors: Aeris Therapeutics; Aeris Therapeutics
Not yet recruiting - verified January 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Procedure: Blood collection; Procedure: Swab collection; Procedure: Sputum collection
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: University of Zurich; University of Zurich
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Usual care; Procedure: self-monitoring for patients with severe COPD; Procedure: nurse-monitoring for patients with severe COPD
Sponsors: Regione Veneto; Regione Veneto; European Commission; Unità Locale Socio Sanitaria di Treviso; Unità Locale Socio Sanitaria Veneziana; Unità Locale Socio Sanitaria di Verona; Unità Locale Socio Sanitaria di Padova; Azienda Ospedaliera di Padova; Azienda Ospedaliera Universitaria Integrata Verona
Recruiting - verified January 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: Home based pulmonary rehabilitation with exercise
Sponsors: University of Nove de Julho; University of Nove de Julho
Recruiting - verified March 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Acute Exacerbation of Chronic Obstructive Airways Disease; Chronic Hypercapnic Respiratory Failure
Intervention: Device: Nightly NIV for at least 6 hours
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen; Philips Respironics
Not yet recruiting - verified January 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: NVA237 50µg once daily; Drug: Tiotropium 18µg once daily; Drug: Placebo; Drug: Fluticasone/Salmeterol
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Procedure: Home telehealth; Other: Usual care
Sponsors: Catalan Agency for Health Information, Assessment and Quality; Catalan Agency for Health Information, Assessment and Quality; Fundació TicSalut; Hospital Clinic of Barcelona; Hospital de Mataró
Not yet recruiting - verified January 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Behavioral: Case Management; Behavioral: Usual Care
Sponsors: Kronikerenheden Nordjylland; Kronikerenheden Nordjylland
Not yet recruiting - verified January 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Procedure: Spirometry
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Inspiratory muscle training; Other: Respiratory exercise
Sponsors: Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos
Recruiting - verified January 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; Lung Diseases, Obstructive; Pulmonary Emphysema; Bronchitis, Chronic; Lung Diseases; Disease Progression
Intervention:
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Medical Research Council
Recruiting - verified January 2012 - Condition: Overlap Syndrome
Intervention: Device: BiPAP ventilation and aotu-trilevel ventilation
Sponsors: Nanjing Medical University; Nanjing Medical University
Recruiting - verified February 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive; Bronchitis, Chronic; Pulmonary Emphysema; Disease Progression
Intervention:
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Medical Research Council; The Hillingdon Hospitals NHS Foundation Trust; West Hertfordshire Hospitals NHS Trust
Recruiting - verified January 2012 - Conditions: Proprioceptive Postural Control; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Katholieke Universiteit Leuven; Katholieke Universiteit Leuven; Universitaire Ziekenhuizen Leuven
Recruiting - verified January 2012 - Conditions: Proprioceptive Postural Control; Respiratory Disorders; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Katholieke Universiteit Leuven; Katholieke Universiteit Leuven; Universitaire Ziekenhuizen Leuven
Not yet recruiting - verified January 2012 - Condition: COPD
Interventions: Drug: AZD2115; Drug: Placebo; Drug: Indacaterol; Drug: Indacaterol + Tiotropium
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Conditions: COPD; Chronic Obstructive Pulmonary Disease
Interventions: Drug: Roflumilast; Drug: Placebo
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Device: High flow therapy (AIRVO, Fisher and Paykel)
Sponsors: Institut für Pneumologie Hagen Ambrock eV; Institut für Pneumologie Hagen Ambrock eV
Recruiting - verified January 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; COPD; Chronic Obstructive Lung Disease; Bronchitis, Chronic; Pulmonary Emphysema
Intervention: Behavioral: Remote Health Monitoring
Sponsors: University of California, Los Angeles; University of California, Los Angeles; eResearch Technology (eRT)
Not yet recruiting - verified December 2011 - Conditions: Invasive Pulmonary Aspergillosis; Chronic Obstructive Pulmonary Disease
Intervention: Drug: caspofungin
Sponsors: The First Affiliated Hospital of Guangzhou Medical University; The First Affiliated Hospital of Guangzhou Medical University; Merck
Recruiting - verified March 2012 - Conditions: Pulmonary Arterial Hypertension; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: University of Florida; University of Florida; United Therapeutics
Recruiting - verified December 2011 - Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.Conditions: Pulmonary Disease, Chronic Obstructive; Obesity Hypoventilation Syndrome; Metabolic Alkalosis
Interventions: Drug: Acetazolamide; Drug: Placebo
Sponsors: Hospital Son Llatzer; Hospital Son Llatzer
Recruiting - verified December 2011 - Condition: Idiopathic Pulmonary Fibrosis
Intervention: Behavioral: Pulmonary Rehabilitation
Sponsors: Rabin Medical Center; Rabin Medical Center
Not yet recruiting - verified December 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: COPD
Interventions: Drug: GSK573719/GW642444; Drug: GSK573719
Sponsors: Queen's University; Queen's University; GlaxoSmithKline
Not yet recruiting - verified December 2011 - Condition: COPD
Intervention: Behavioral: Breathing control in patients with COPD
Sponsors: Lovisenberg Diakonale Hospital; Lovisenberg Diakonale Hospital; University of Oslo; Norwegian Foundation for Health and Rehabilitation; University of Bergen
Recruiting - verified January 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Procedure: Telemonitoring; Other: Usual Care
Sponsors: Regional Health Authority of Sterea & Thessaly; Regional Health Authority of Sterea & Thessaly; Ministry of Health and Social Welfare, Greece; Municipality of Trikala, Greece; e-trikala SA, Trikala, Greece; Cities Net SA, Trikala, Greece; Biomedical Research & Technology (BIOMED, Larissa, Greece; Institute of Communications and Computer Systems (ICCS), Athens, Greece; Technological Educational Institute of Thessaloniki, Greece; University of Macedonia, Thessaloniki, Greece; Faculty of Medicine, University of Thessaly, Greece
Recruiting - verified December 2011 - Condition: COPD
Interventions: Drug: Peforomist-Placebo; Drug: Perforomist, nebulization, COPD
Sponsors: Dey; Dey
Not yet recruiting - verified November 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Device: TLD Therapy (IPS SystemTM)
Sponsors: Innovative Pulmonary Solutions, Inc.; Innovative Pulmonary Solutions, Inc.
Recruiting - verified January 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: Placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Roflumilast; Drug: Placebo of Roflumilast; Radiation: Functional Respiratory Imaging
Sponsors: FluidDA nv; FluidDA nv
Recruiting - verified May 2012 - Conditions: Chronic Bronchiectasis; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Procedure: Conventional Chest Physiotherapy (CCPT); Device: Mechanical percussion (LEGA)
Sponsors: Penang Hospital, Malaysia; Penang Hospital, Malaysia
Not yet recruiting - verified November 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Pulmonary daoyin therapy of China; Other: usual care
Sponsors: Henan University of Traditional Chinese Medicine; Henan University of Traditional Chinese Medicine
Not yet recruiting - verified October 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Glycopyrrolate; Drug: Glycopyrrolate; Drug: Glycopyrrolate; Drug: Comparator
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Not yet recruiting - verified November 2011 - Condition: Cardiovascular Disease
Intervention: Procedure: Spirometry
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Traditional Chinese Medicine; Drug: placebo chinese medicine
Sponsors: Henan University of Traditional Chinese Medicine; Henan University of Traditional Chinese Medicine
Not yet recruiting - verified December 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide; Drug: Placebo
Sponsors: Almirall, S.A.; Almirall, S.A.; Forest Laboratories
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust
Recruiting - verified December 2011 - Conditions: COPD; Hypercapnia
Interventions: Device: humidified transnasal insufflation (TNI20oxy); Other: overnight oxygen treatment with individual flow rate
Sponsors: Institut für Pneumologie Hagen Ambrock eV; Institut für Pneumologie Hagen Ambrock eV; TNI medical AG
Recruiting - verified December 2011 - Condition: Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation
Interventions: Drug: Roflumilast; Drug: Placebo
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Conditions: Chronic Obstructive Pulmonary Diseases; Chronic Airways Limitation; Bronchitis
Interventions: Drug: Mepolizumab; Drug: placebo
Sponsors: McMaster University; McMaster University
Recruiting - verified October 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide; Drug: Placebo; Drug: Formoterol Fumarate
Sponsors: Almirall, S.A.; Almirall, S.A.; Forest Laboratories
Recruiting - verified October 2011 - Conditions: Pulmonary Emphysema; COPD; Lung Diseases
Intervention: Device: AeriSeal System
Sponsors: LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology; LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology
Recruiting - verified October 2011 - Conditions: Weaning of Mechanical Ventilation; Chronic Obstructive Pulmonary Disease
Interventions: Procedure: "T" Tube Spontaneous Breathing Trial; Procedure: Pressure Support Ventilation
Sponsors: Hospital Nossa Senhora da Conceicao; Hospital Nossa Senhora da Conceicao
Not yet recruiting - verified November 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Cardiovascular Diseases; Lung Cancer
Intervention:
Sponsors: Region Skane; Region Skane
Not yet recruiting - verified October 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Device: BiPAP Pro 2, Phillips Respironics; Device: CPAP sham
Sponsors: National Institute of Respiratory Diseases, Mexico; National Institute of Respiratory Diseases, Mexico
Recruiting - verified May 2012 - Condition: Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure
Intervention:
Sponsors: MedImmune LLC; MedImmune LLC; AstraZeneca AB
Recruiting - verified April 2012 - Condition: Pulmonary Emphysema
Interventions: Device: EBV implantation; Device: IBV implantation
Sponsors: University of Heidelberg; University of Heidelberg
Recruiting - verified October 2011 - Condition: Chronic Respiratory Insufficiency
Interventions: Other: NIV during rehabilitation; Other: Rehabilitation without NIV
Sponsors: Fondazione Salvatore Maugeri; Fondazione Salvatore Maugeri; Villa Pineta Hospital; University of Modena and Reggio Emilia; Azienda Ospedaliero, Universitaria Pisana; Ataturk Training and Research Hospital
Recruiting - verified October 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Biological: MEDI8968 SC for 12 months; Biological: Placebo SC for 12 months
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified May 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Fatigue
Interventions: Other: Laser therapy; Other: Placebo laser therapy
Sponsors: University of Nove de Julho; Eduardo Foschini Miranda
Not yet recruiting - verified April 2012 - Condition: Pulmonary Emphysema
Intervention: Device: polymeric lung volume reduction system ( AeriSeal System)
Sponsors: Aeris Therapeutics; Aeris Therapeutics
Not yet recruiting - verified January 2012 - Conditions: COPD; COPD Exacerbation; Lung Diseases; Respiratory Disorders; Pulmonary Disease; Chronic Obstructive Lung Diseases; Chronic Obstructive Airway Disease
Interventions: Drug: Roflumilast; Drug: Placebo
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Tiotropium; Drug: placebo
Sponsors: The First Affiliated Hospital of Guangzhou Medical University; The First Affiliated Hospital of Guangzhou Medical University; Boehringer Ingelheim Int'l Trading (Shanghai) Co., Ltd; Rundo International Pharmaceutical Research & Development Co.,Ltd.
Recruiting - verified January 2012 - Conditions: Pulmonary Hypertension; Chronic Obstructive Pulmonary Disease
Interventions: Drug: Iloprost; Drug: Placebo
Sponsors: Actelion; Actelion
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide; Drug: Formoterol Fumarate; Drug: placebo
Sponsors: Forest Laboratories; Forest Laboratories; Almirall, S.A.
Recruiting - verified March 2012 - Condition: COPD Exacerbation
Interventions: Drug: ceftidoren; Drug: levofloxacin
Sponsors: University of Milan; University of Milan
Recruiting - verified February 2012 - Conditions: Healthy; COPD
Interventions: Drug: Indacaterol maleate; Drug: Tiotropium bromide
Sponsors: University of Milan; University of Milan; Fondazione Salvatore Maugeri
Recruiting - verified September 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: olodaterol; Drug: tiotropium; Drug: tiotropium + olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium + olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Obstructive Chronic Pulmonary Disease; Emphysema; Chronic Bronchitis
Intervention: Other: Combined Training (endurance and strength exercises)
Sponsors: Hospitales Universitarios Virgen del Rocío; Hospitales Universitarios Virgen del Rocío; Fondo de Investigacion Sanitaria
Recruiting - verified September 2011 - Conditions: Referral; Quality of Health Care
Intervention: Other: Implementation of referral template
Sponsors: University Hospital of North Norway; University Hospital of North Norway; University of Tromso
Recruiting - verified April 2012 - Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Behavioral: Teach-To-Goal; Behavioral: Brief Intervention
Sponsors: University of Chicago; University of Chicago
Recruiting - verified September 2011 - Continuous Positive Airway Pressure Versus Noninvasive Ventilation in Patients With Overlap SyndromeConditions: Chronic Obstructive Pulmonary Disease; Obstructive Sleep Apnea; Overlap Syndrome
Intervention: Procedure: Bipap procedure
Sponsors: United States Air Force; United States Air Force; Landstuhl Regional Medical Center; Good Samaritan Hospital; Dayton Respiratory Center; Tripler Army Medical Center
Not yet recruiting - verified August 2011 - Conditions: Hypertension, Pulmonary; Pulmonary Disease, Chronic Obstructive
Intervention:
Sponsors: Wissenschaftliches Institut Bethanien e.V; Wissenschaftliches Institut Bethanien e.V; Actelion Pharmaceuticals Deutschland GmbH
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: Balance training program
Sponsors: West Park Healthcare Centre; Roger Goldstein; Ontario Lung Association
Recruiting - verified August 2011 - Condition: COPD
Intervention:
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Condition: Chronic Obstructive Lung Disease
Interventions: Dietary Supplement: Vitamin D (D3, cholecalciferol); Dietary Supplement: Placebo (cellulose)
Sponsors: Hvidovre University Hospital; Jorgen Vestbo
Recruiting - verified September 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Behavioral: Home-based pulmonary rehabilitation; Behavioral: Hospital-based pulmonary rehabilitation
Sponsors: La Trobe University; La Trobe University; The Alfred; Austin Health; Monash University
Not yet recruiting - verified August 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Drug: Budesonide/formoterol (Symbicort Turbuhaler; Drug: Drug: ipratropium (AtroventTM ); Drug: theophylline SR
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Cardiac Decompensation
Intervention:
Sponsors: Aventyn, Inc.; Aventyn, Inc.; AT&T; BMS Hospital Trust; University of California; Zephyr Technology
Recruiting - verified September 2011 - Condition: COPD Exacerbation
Intervention: Device: minimally invasive extracorporeal carbon dioxide removal
Sponsors: University of Turin, Italy; University of Turin, Italy
Recruiting - verified August 2011 - Conditions: COPD; Bronchiectasis
Intervention:
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified May 2011 - Conditions: Pulmonary Hypertension; COPD
Interventions: Drug: Sildenafil citrate; Drug: Sugar pills
Sponsors: Italian Association of Hospital Pneumologists; Italian Association of Hospital Pneumologists
Recruiting - verified September 2011 - Condition: COPD Exacerbation
Intervention:
Sponsors: Hull and East Yorkshire Hospitals NHS Trust; Hull and East Yorkshire Hospitals NHS Trust; Philips Respironics
Recruiting - verified March 2012 - Condition: Chronic Obstructive Lung Disease, Moderate Severity
Intervention: Drug: Iodinated Active Charcoal (IodoCarb)
Sponsors: PharmaLundensis AB; PharmaLundensis AB
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tetrahydrobiopterin (BH4); Drug: non-acetylated salicylate; Dietary Supplement: High Fat Meal; Drug: L-NMMA; Dietary Supplement: Antioxidant Cocktail
Sponsors: Georgia Health Sciences University; Georgia Health Sciences University; American Heart Association
Recruiting - verified July 2011 - Condition: Acute Exacerbation of Chronic Obstructive Airways Disease
Interventions: Procedure: seamless discharge; Procedure: Usual care
Sponsors: Ward of the 21st Century; Ward of the 21st Century; Canadian Institutes of Health Research (CIHR); Alberta Health Services
Not yet recruiting - verified October 2010 - Condition: Chronic Obstructive Pulmonary Disease (COPD).
Interventions: Drug: Moxifloxacin; Drug: Azithromycin; Drug: Doxycycline; Drug: Placebo
Sponsors: University College, London; University College, London; Royal Free Hampstead NHS Trust; University of Cambridge; National Institute for Health Research, United Kingdom
Recruiting - verified June 2011 - Conditions: COPD; Inspiratory Muscle Weakness
Intervention: Procedure: Inspiratory Muscle Training
Sponsors: Katholieke Universiteit Leuven; Katholieke Universiteit Leuven
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) 100/25 mcg Novel Dry Powder Inhaler (NDPI); Drug: Tiotropium
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Columbia University; Columbia University; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Condition: COPD Exacerbation
Interventions: Device: Automated settings on the oxygen delivery device; Device: Manual settings with FreeO2 system in collection mode
Sponsors: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec; Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Recruiting - verified May 2011 - Conditions: COPD; Pulmonary Emphysema
Intervention:
Sponsors: University of Heidelberg; University of Heidelberg
Recruiting - verified April 2010 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: arformoterol; Drug: salmeterol
Sponsors: Dartmouth-Hitchcock Medical Center; Dartmouth-Hitchcock Medical Center; Sunovion
Recruiting - verified March 2012 - Condition: Thoracic Aortic Surgery
Intervention: Other: Electronic Medical Record (EMR) Review
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention:
Sponsors: Centre for Research in Environmental Epidemiology, Spain; Centre for Research in Environmental Epidemiology, Spain; Katholieke Universiteit Leuven; University of Edinburgh; Royal Brompton & Harefield NHS Foundation Trust; University Medical Centre Groningen; University of Athens
Recruiting - verified October 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Procedure: Education
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Budesonide/formoterol (Symbicort® Turbuhaler®); Drug: Tiotropium (SpirivaTM)
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified January 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Procedure: pulmonary rehabilitation with NIV; Procedure: Pulmonary rehabilitation without NIV
Sponsors: Klinikum Berchtesgadener Land der Schön-Kliniken; Klinikum Berchtesgadener Land der Schön-Kliniken; ResMed
Recruiting - verified December 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: education intervention
Sponsors: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Servicio Murciano de salud; Consejeria de sanidad.Direccion general de planificacion, ordenacion sanitaria y farmaceutica e investigacion.; AstraZeneca
Recruiting - verified June 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Alpha-1-antitrypsin-deficiency
Intervention: Procedure: exercise training
Sponsors: Klinikum Berchtesgadener Land der Schön-Kliniken; Klinikum Berchtesgadener Land der Schön-Kliniken; Grifols Therapeutics Inc.; Alpha-1 Foundation
Recruiting - verified November 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Imperial College London; Imperial College London
Not yet recruiting - verified June 2011 - Condition: Pulmonary Sarcoidosis
Intervention:
Sponsors: Meir Medical Center; Meir Medical Center
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: ketoconazole; Drug: inert powder
Sponsors: Dartmouth-Hitchcock Medical Center; Dartmouth-Hitchcock Medical Center
Recruiting - verified March 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone furoate/vilanterol; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Conditions: Asthma; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified June 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Device: Breathe Technologies Noninvasive Open Ventilation (NIOV™) System
Sponsors: Breathe Technologies, Inc.; Breathe Technologies, Inc.
Recruiting - verified April 2012 - Conditions: Chronic Hypercapnic Respiratory Failure; Obesity Hypoventilation Syndrome; Neuromuscular Disease; Chronic Obstructive Pulmonary Disease
Intervention: Other: Surface parasternal electromyelography (EMG) set up
Sponsors: Guy's and St Thomas' NHS Foundation Trust; Guy's and St Thomas' NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust
Recruiting - verified January 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Chronic Respiratory Hypercapnic Failure; Neuromuscular Disease; Obesity Hypoventilation Syndrome
Intervention: Device: non-invasive ventilation heated humidification (Fisher-Paykel MR810 and MR850 humidifiers)
Sponsors: Guy's and St Thomas' NHS Foundation Trust; Guy's and St Thomas' NHS Foundation Trust
Not yet recruiting - verified March 2011 - Conditions: Coronary Artery Disease; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Emory University; Emory University
Recruiting - verified May 2011 - Conditions: Lung Disease, Obstructive; Tuberculosis
Intervention:
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Recruiting - verified June 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Interventions: Procedure: Blood sample; Procedure: Sputum sample; Procedure: Nasopharyngeal swab; Procedure: Urine sample; Procedure: End tidal breath sample; Other: Data collection; Other: Tests
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Conditions: Chronic Obstructive Pulmonary Disease; COPD; Emphysema; Chronic Bronchitis
Interventions: Drug: Nebulized arformoterol; Drug: Salmeterol
Sponsors: University of California, Los Angeles; University of California, Los Angeles
Recruiting - verified June 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Inhalation gas; Drug: Inhalation Nitrogen/Oxygen; Drug: Inhalation Helium/Oxygen
Sponsors: Air Liquide SA; Air Liquide SA; Asklepios Kliniken Hamburg GmbH
Recruiting - verified October 2011 - Conditions: Pharyngitis; Acute Tonsillitis; Rhinosinusitis; Acute Bronchitis; Chronic Obstructive Pulmonary Disease
Intervention: Other: Antibiotic prescription strategies
Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Recruiting - verified May 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Foster® 100/6 µg/unit dose; Drug: Symbicort® Turbohaler® 200/6 μg/actuation
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Recruiting - verified October 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Idiopathic Pulmonary Fibrosis
Intervention: Drug: Sildenafil
Sponsors: Rabin Medical Center; Rabin Medical Center
Not yet recruiting - verified June 2011 - Condition: Lung Cancer
Intervention:
Sponsors: Sheba Medical Center; Sheba Medical Center
Recruiting - verified February 2012 - Conditions: Ischemic Heart Disease; Heart Failure; Chronic Kidney Disease; Diabetes; Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: iCDM
Sponsors: Simon Fraser University; Simon Fraser University; Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research
Recruiting - verified April 2011 - Conditions: Chronic Pulmonary Obstructive Disease; Emphysema
Intervention:
Sponsors: Aeris Therapeutics; Aeris Therapeutics
Recruiting - verified October 2011 - Conditions: Pulmonary Disease, Chronic Obstructive; Muscular Atrophy
Interventions: Dietary Supplement: Dietary supplementation; Dietary Supplement: Placebo supplement; Behavioral: Nutritional counselling; Behavioral: Feedback on physical activity level
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; The Netherlands Asthma Foundation; Danone Research
Recruiting - verified September 2011 - Condition: COPD
Interventions: Dietary Supplement: Sulforaphane 25; Dietary Supplement: Sulforaphane 150; Other: Placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; Temple University; State University of New York at Buffalo
Recruiting - verified October 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: BCT197; Drug: BCT197 placebo; Drug: Prednisone placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: PUR118
Sponsors: Pulmatrix Inc.; Pulmatrix Inc.; Quotient Bioresearch
Recruiting - verified November 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone Furoate/Vilanterol; Drug: Vilanterol; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Roflumilast; Drug: Placebo
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Condition: COPD
Intervention: Drug: Acetylsalicylic acid
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified June 2011 - Conditions: Depression; Heart Failure; Chronic Obstructive Pulmonary Disease
Interventions: Behavioral: Combined Psychotherapy and Illness Management; Behavioral: Illness Management Only
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified November 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Respiratory Muscle Blood Flow
Interventions: Other: Near Infrared Spectroscopy; Other: Near Infrared Spectroscopy
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified December 2011 - Conditions: Chronic Obstructive Pulmonary Disease; COPD
Interventions: Drug: Combination Fluticasone /Formoterol 12/250 μg; Drug: Seretide Diskus (salmeterol/fluticasone) 50/250 μg
Sponsors: Ache Laboratorios Farmaceuticos S.A.; Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting - verified July 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Emphysema
Intervention:
Sponsors: Villa Pineta Hospital; Prof. Clini Enrico
Recruiting - verified October 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Spa therapy; Other: No spa therapy
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Katholieke Universiteit Leuven; Katholieke Universiteit Leuven; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified June 2011 - Conditions: Pulmonary Disease, Chronic Obstructive; Cardiovascular Disease
Interventions: Drug: fluticasone furoate/vilanterol; Drug: fluticasone furoate; Drug: vilanterol; Other: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Severe COPD
Intervention: Drug: Daxas
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Condition: Patients Needing Blood Gases
Intervention: Other: Venous Blood Gas
Sponsors: Christiana Care Health Services; Christiana Care Health Services
Recruiting - verified August 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Indacaterol 150 µg once-daily via single-dose dry powder inhaler
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Nasal Polyp; Smoking; Rhinosinusitis; Allergic Rhinitis; Deviated Nasal Septum; ASA Intolerant Asthma
Intervention:
Sponsors: Karnataka Institute of Medical Sciences; Karnataka Institute of Medical Sciences; Ministry of Science and Technology, India; Applied Genetics; Lab Discoveries Ltd.
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Tiotropium; Drug: Salmeterol; Drug: Formoterol
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; Olmsted Medical Center; American Academy of Family Physicians National Research Network; Harvard Clinical Research Institute
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: Tai chi + standard pulmonary rehabilitation program
Sponsors: Kwong Wah Hospital; Kwong Wah Hospital
Recruiting - verified November 2010 - Conditions: COPD Method Evaluation; Chronic Obstructive Pulmonary Disease Method Evaluation
Interventions: Drug: Formoterol Turbuhaler; Drug: Budesonide/Formoterol Turbuhaler; Drug: Formoterol Turbuhaler
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Other: Mud bath Therapy
Sponsors: Fondazione Salvatore Maugeri; Fondazione Salvatore Maugeri
Recruiting - verified December 2010 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Atimos®; Drug: Serevent™; Drug: Placebo
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Recruiting - verified February 2012 - Condition: COPD
Intervention:
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention:
Sponsors: Philipps University Marburg Medical Center; Philipps University Marburg Medical Center; Hannover Medical School; Ludwig-Maximilians - University of Munich
Recruiting - verified July 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Budesonide+ ipratropium/albuterol; Drug: budesonide/formoterol plus ipratropium/albuterol; Drug: Ipratropium/albuterol
Sponsors: National Jewish Health; National Jewish Health; AstraZeneca
Recruiting - verified April 2012 - Conditions: Emphysema; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Pulmonary Fibrosis; Bronchiectasis; Sarcoidosis; Pulmonary Hypertension; Alpha-1 Antitrypsin Deficiency
Intervention: Procedure: Transplantation of Lungs After Ex-vivo Perfusion w/ STEEN Solution™
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Duke University; National Heart, Lung, and Blood Institute (NHLBI); Vitrolife; XVIVO Perfusion
Recruiting - verified September 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Other: Disease Management; Other: Usual site management
Sponsors: Air Liquide Santé International; Air Liquide Santé International; ITEC Services; Lincoln
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Other: provider support tools plus spirometer
Sponsors: Memorial Hospital of Rhode Island; Memorial Hospital of Rhode Island; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Indacaterol; Drug: Comparator
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified December 2011 - Conditions: COPD; Exacerbation; Bronchitis; Sputum; C-Reactive Protein
Intervention: Other: CRP-guided antibiotic treatment
Sponsors: Medical Center Alkmaar; Medical Center Alkmaar
Recruiting - verified March 2012 - Condition: Lung Diseases
Interventions: Device: Exercise DVD; Behavioral: Usual Care
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Capital Health, Canada
Recruiting - verified July 2011 - The Expression of TLR2 and TLR4 in the Lung of Chronic Obstructive Pulmonary Disease (COPD) PatientsConditions: Smoking; COPD
Intervention:
Sponsors: Seoul National University Bundang Hospital; Seoul National University Bundang Hospital
Recruiting - verified June 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Physical Activity
Intervention: Behavioral: Activity monitor/smartphone health coaching
Sponsors: Mayo Clinic; Mayo Clinic; National Institute on Aging (NIA)
Recruiting - verified April 2012 - Conditions: Lung Transplantation; Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Katholieke Universiteit Leuven; Katholieke Universiteit Leuven
Recruiting - verified July 2011 - Conditions: Healthy Subjects; Chronic Liver Disease; Cirrhosis
Interventions: Device: 13C Methacetin Breath Test; Dietary Supplement: Grape fruit juice; Drug: Non selective beta blocker - Propranolol; Dietary Supplement: Ethanol
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization; Exalenz Bioscience LTD.
Recruiting - verified June 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: domiciliary rehabilitation; Other: Standard Care
Sponsors: Associazione Riabilitatori Insufficienza Respiratoria; Associazione Riabilitatori Insufficienza Respiratoria
Recruiting - verified January 2012 - Condition: COPD
Intervention: Device: Lung Flute
Sponsors: Medical Acoustics LLC; Nicolaas J Smit PhD
Recruiting - verified August 2011 - Condition: LUNG DISEASES, OBSTRUCTIVE
Interventions: Device: pulse oxygen supplementation devices; Device: continuous oxygen
Sponsors: Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire; Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire
Recruiting - verified February 2012 - Condition: COPD
Interventions: Behavioral: Telehealth consultation; Other: Conventional care
Sponsors: University of Southern Denmark; University of Southern Denmark; Odense University Hospital
Recruiting - verified June 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Dietary Supplement: Essential amino acid intake + Leucine vs total AA supplement
Sponsors: University of Arkansas; University of Arkansas
Recruiting - verified February 2012 - Conditions: Left Ventricular Systolic Dysfunction; Mitral Regurgitation
Intervention:
Sponsors: Imperial College London; Imperial College London; Humboldt-Universität zu Berlin; British Heart Foundation
Recruiting - verified August 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Helium/Oxygen 78%/22%; Drug: Air/Oxygen
Sponsors: Air Liquide Santé International; Air Liquide Santé International
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Physical exercise training with supplemental oxygen; Other: Physical exercise training with "room air supplementation"
Sponsors: Paracelsus Medical University; Paracelsus Medical University; Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University
Recruiting - verified September 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Telemedicine
Intervention: Other: Telemedical admission and treatment in the patients´ own homes instead of conventional admission and treatment at the hospital
Sponsors: Frederiksberg University Hospital; Frederiksberg University Hospital; TRYG Foundation; The TOYOTA Foundation; Helsefonden; Lykfeldt legat; Frederiksberg Fonden; Danmarks Lungeforening
Recruiting - verified October 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Simvastatin; Drug: Lactose tablet
Sponsors: University of Nottingham; University of Nottingham
Recruiting - verified January 2012 - Conditions: Osteoporosis; Obstructive Lung Disease
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Heart Failure; Anxiety; Depression
Intervention: Behavioral: Adjusting to Chronic Conditions Using Education, Support, and Skills
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Conditions: Obesity; Chronic Obstructive Pulmonary Disease
Intervention: Device: Ventilator setting changes
Sponsors: Bridgeport Hospital; Bridgeport Hospital
Recruiting - verified March 2010 - Condition: COPD
Intervention:
Sponsors: Cimera; Cimera
Recruiting - verified June 2011 - Condition: COPD
Interventions: Dietary Supplement: Magnesium supplement (magnesium hydroxide/ -oxide); Dietary Supplement: Placebo
Sponsors: University of Aarhus; University of Aarhus; Gunnar Kjems APS; Dept. of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Dietary Supplement: Magnesium supplement (magnesium hydroxide/ -oxide); Dietary Supplement: Placebo
Sponsors: University of Aarhus; University of Aarhus; Gunnar Kjems APS; GCP-unit at Aarhus University Hospital, Aarhus, Denmark; Dept. of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: Comprehensive care programme
Sponsors: Chinese University of Hong Kong; Chinese University of Hong Kong
Recruiting - verified June 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Behavioral: automated internet-mediated walking program
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified January 2012 - Conditions: Chronic Obstructive Pulmonary Disease (COPD); Asthma
Interventions: Other: Pulmonary disease management; Other: Usual care
Sponsors: Sheba Medical Center; Sheba Medical Center; Maccabi Health Services
Recruiting - verified June 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Procedure: Fiberoptic bronchoscopy; Procedure: blood draw; Procedure: intravenous catheter
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Moxifloxacin
Sponsors: Fundacion Clinic per a la Recerca Biomédica; Fundacion Clinic per a la Recerca Biomédica; Instituto de Salud Carlos III
Recruiting - verified April 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: SCH 527123; Drug: SCH 527123; Drug: SCH 527123; Drug: SCH 527123; Drug: Placebo; Drug: SCH 527123; Drug: SCH 527123; Drug: SCH 527123; Drug: Placebo
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: simvastatin; Drug: Placebo
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Behavioral: Self-Management and Motivational Interviewing
Sponsors: Mayo Clinic; Mayo Clinic; HealthPartners Research Foundation; Olmsted Medical Center
Recruiting - verified April 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Nocturnal Desaturation
Interventions: Device: Concentrator; Device: Sham concentrator
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified February 2012 - Condition: Mature B-Cell Lymphoma
Interventions: Drug: COPAD; Drug: COP, COPD M3, CYM; Drug: COP, COPADM8, CYVE
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified April 2012 - Conditions: Cancer; Congestive Heart Failure (CHF); Chronic Obstructive Pulmonary Disease (COPD); End Stage Renal Disease (ESRD)
Interventions: Other: Life Completion; Other: Attention Control; Other: True control
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Conditions: Obstructive Sleep Apnea; Chronic Obstructive Pulmonary Disease
Intervention: Device: CPAP
Sponsors: University of Oklahoma; University of Oklahoma
Recruiting - verified January 2012 - Condition: Chronic Hypercapnic Respiratory Failure
Interventions: Device: heated humidification; Device: heat and moisture exchanger; Device: usual mechanical ventilation without humidification
Sponsors: Fondazione Salvatore Maugeri; Fondazione Salvatore Maugeri
Recruiting - verified December 2009 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Procedure: Lung volume reduction surgery; Other: No LVRS group
Sponsors: University of Zurich; University of Zurich
Recruiting - verified January 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Oslo University Hospital; Oslo University Hospital; University of California, San Francisco
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Fosinopril; Other: lactose
Sponsors: Imperial College London; Imperial College London; Medical Research Council
Recruiting - verified June 2011 - Condition: Lung Transplantation
Intervention: Drug: mycophenolate mofetil [CellCept]
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified December 2011 - Conditions: Pulmonary Disease; Chronic Obstructive
Interventions: Other: breathing retraining; Other: exercise training
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified January 2012 - Conditions: Retinal Artery; Retinal Veins
Intervention:
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified October 2009 - Conditions: Asthma; COPD
Intervention: Drug: broccoli sprout extract
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Device: Non invasive ventilation; Device: LTOT
Sponsors: Guy's and St Thomas' NHS Foundation Trust; Patrick Murphy; Guy's & St Thomas' Charity; Respironics International; ResMed; ResMed Foundation
Recruiting - verified May 2012 - Condition: COPD
Interventions: Drug: Azithromycin; Drug: Placebo
Sponsors: Amphia Hospital; Amphia Hospital; Erasmus Medical Center; Stichting Solong
Recruiting - verified May 2010 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: CTX-100 (formerly ETX-100) (hyaluronic acid)
Sponsors: Turino, Gerard, M.D.; Turino, Gerard, M.D.
Recruiting - verified June 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Other: Disease management; Other: Best care
Sponsors: Sheba Medical Center; Sheba Medical Center; Clalit Health Services
Recruiting - verified June 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium +salmeterol+ fluticasone high dose; Drug: Tiotropium+salmeterol+ fluticasone high,med, low, placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Cyclosporine
Sponsors: University of Pittsburgh; University of Pittsburgh; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified September 2011 - Conditions: Chronic Obstructive Pulmonary Disease; Smoking; Smoking Cessation; Healthy Smoker; Smoker; Chronic Bronchitis; Emphysema
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Device: A unidirectional face mask (Modified 'Respironics PerformaTrak' Mask)
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Not yet recruiting - verified April 2012 - Conditions: Pulmonary Disease, Chronic Obstructive; Respiratory Insufficiency
Intervention: Device: Vapotherm High Flow Therapy
Sponsors: Vapotherm, Inc.; Vapotherm, Inc.
Recruiting - verified October 2009 - Conditions: COPD Patients; Healthy Subjects; Semi-supine Echo (SSE); Flow-mediated Vasodilatation (FMD); High Sensitive C-reactive Protein (hsCRP)
Interventions: Other: Measure pulmonary artery pressure change during exercise; Other: Pulmonary pressure response during exercise
Sponsors: Szeged University; Szeged University
Recruiting - verified October 2009 - Conditions: Bronchiectasis; Cystic Fibrosis; Autoimmune Disease; Common Variable Immunodeficiency
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Smoking
Interventions: Device: deep TMS HADD coil; Device: sham deep TMS HADD coil
Sponsors: BeerYaakov Mental Health Center; BeerYaakov Mental Health Center
Recruiting - verified October 2011 - Condition: COPD
Interventions: Drug: Rosuvastatin; Drug: Placebo
Sponsors: University Hospital, Akershus; University Hospital, Akershus; AstraZeneca; Haukeland University Hospital, Bergen
Recruiting - verified April 2012 - Conditions: Low Birth Weight; Small for Gestational Age; Immunodeficiency
Intervention: Other: Cord blood collection for analysis
Sponsors: University of Utah; University of Utah; Department of Health and Human Services
Recruiting - verified December 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: Johns Hopkins University; Johns Hopkins University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2011 - Condition: Interstitial Lung Disease
Interventions: Other: Pulmonary Rehabilitation; Other: Control
Sponsors: Katholieke Universiteit Leuven; Katholieke Universiteit Leuven
Recruiting - verified June 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: tetomilast; Drug: placebo
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: OXYGEN SUPPLEMENTATION
Sponsors: Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire; Association Nationale pour le Traitement à Domicile de l'Insuffisance Respiratoire
Recruiting - verified February 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Lung Cancer
Intervention:
Sponsors: Katholieke Universiteit Leuven; Katholieke Universiteit Leuven
Recruiting - verified June 2011 - Conditions: Sleep-disordered Breathing; Chronic Heart Failure
Intervention:
Sponsors: LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology; LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology
Recruiting - verified June 2011 - Conditions: Asthma; Copd
Intervention:
Sponsors: University Medical Centre Groningen; University Medical Centre Groningen
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Beclomethasone
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Chronic Obstructive Lung Disease
Intervention:
Sponsors: Ohio State University; Ohio State University
Recruiting - verified August 2011 - Condition: Kartagener Syndrome
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Salbutamol + Tiotropium; Drug: Placebo + Tiotropium
Sponsors: Fondazione Salvatore Maugeri; Fondazione Salvatore Maugeri
Recruiting - verified December 2009 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Dietary Supplement: n-3 polyunsaturated fatty acids; Other: Placebo
Sponsors: Columbia University; Columbia University; National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified February 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Behavioral: Telephone-based Enhanced Coping Skills Training (CST); Other: Usual Medical Care and COPD education and symptom monitoring (UMC)
Sponsors: Duke University; Duke University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2011 - Conditions: COPD; Pulmonary Hypertension
Interventions: Drug: sildenafil; Drug: placebo
Sponsors: University of Aarhus; University of Aarhus; Aarhus University Hospital
Not yet recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Lovastatin; Drug: Placebo
Sponsors: National Jewish Health; National Jewish Health; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: Supplemental oxygen therapy
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI); Centers for Medicare and Medicaid Services
Recruiting - verified April 2012 - Conditions: Advanced Cancer; Chronic Obstructive Pulmonary Disease (COPD); Restrictive Lung Disease; Congestive Heart Failure; End Stage Liver Disease
Intervention: Behavioral: Training Program Intervention
Sponsors: University of Washington; University of Washington; National Institute of Nursing Research (NINR)
Recruiting - verified April 2012 - Condition: Lung Neoplasms
Intervention:
Sponsors: Menssana Research, Inc.; Menssana Research, Inc.
Recruiting - verified June 2011 - Condition: Lung Diseases
Intervention:
Sponsors: Lung Clinic Hemer; Lung Clinic Hemer
Recruiting - verified May 2011 - Conditions: Pulmonary Disease, Chronic Obstructive; Depression
Interventions: Behavioral: Problem-solving therapy (PST); Behavioral: Adherence-enhanced procedures (AE)
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified August 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Azithromycin; Drug: Placebo
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: tiotropium; Drug: long acting beta agonist
Sponsors: University of Alberta; University of Alberta; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified July 2011 - Conditions: Asthma; COPD; Interstitial Lung Disease; Cystic Fibrosis; Lung Cancer
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University; Weill Cornell Medical College in Qatar; Hamad Medical Corporation
Recruiting - verified August 2011 - Conditions: COPD; Congestive Heart Failure; Asthma; Respiratory Distress Syndrome, Adult; Pneumonia
Intervention:
Sponsors: Tufts Medical Center; Tufts Medical Center
Recruiting - verified July 2011 - Conditions: Asthma; COPD
Intervention: Drug: salbutamol
Sponsors: University of Saskatchewan; University of Saskatchewan
Recruiting - verified May 2012 - Conditions: Asthma; COPD; Interstitial Lung Disease; Cystic Fibrosis; Lung Cancer
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Conditions: Pulmonary Disease; Oropharyngeal Disease; Lymphangioleiomyomatosis; Pulmonary Fibrosis; Asthma; Sarcoidosis
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Conditions: Lung Disease; Bronchitis; Emphysema; COPD; Asthma
Interventions: Procedure: Bronchopulmonary Lung Lavage; Procedure: Bronchial Brushing; Procedure: Bronchial Wall Biopsy
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified August 2011 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: St. Joseph's Healthcare Hamilton; St. Joseph's Healthcare Hamilton
Recruiting - verified July 2011
 |
Join Clinical Trials in the District of Columbia |
